Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) FCF Margin (2009 - 2026)

Updated

Alnylam Pharmaceuticals' FCF Margin came in at 22.62% for Q2 2026, up 7.69 percentage points from 14.93% a year earlier and up 18.45 percentage points from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) FCF Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alnylam Pharmaceuticals reported FCF Margin of 17.07%, up 21.18 percentage points year-over-year; for FY2025, it was 12.53%, up 14.43 percentage points from FY2024.

  • FCF Margin carries a five-year change of +151.58 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -1.89% in FY2024 (-4.19 pp), 2.29% in FY2023 (+61.42 pp), -59.12% in FY2022 (+25.93 pp) and -85.05% in FY2021 (+54.00 pp).
  • The five-year range for quarterly FCF Margin is -430.94% (Q1 2025) to 45.61% (Q3 2023).
  • Year-over-year, FCF Margin has increased for four consecutive quarters, with an average year-over-year change of +4.11 percentage points over the last eight quarters.
  • The fastest year-over-year change in FCF Margin over five years came in Q1 2026 (a gain of 435.11 percentage points), and the weakest in Q1 2025 (a drop of 411.83 percentage points).
  • Business Quant data shows ALNY's FCF Margin at 4.17% (Q1 2026), 12.79% (Q4 2025) and 27.13% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 28.82%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 18.33%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 26.96%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 43.05%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 34.72%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 34.70%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 44.00%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 30.39%
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 22.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.62%
Mar 31, 2026 4.17%
Dec 31, 2025 12.79%
Sep 30, 2025 27.13%
Jun 30, 2025 14.93%
Dec 31, 2024 -17.49%
Sep 30, 2024 7.89%
Jun 30, 2024 17.60%
Mar 31, 2024 -19.11%
Dec 31, 2023 -10.26%
Sep 30, 2023 45.61%
Jun 30, 2023 -23.50%
Mar 31, 2023 -56.49%
Dec 31, 2022 -45.85%
Sep 30, 2022 -49.86%
Jun 30, 2022 -61.77%
Mar 31, 2022 -88.65%
Dec 31, 2021 -66.54%
Sep 30, 2021 -85.33%
Jun 30, 2021 -60.35%
API Access

Alnylam Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY